Rutherford has four cancer centres within its network; located in South Wales, North East, Thames Valley and the North West. The centres offer radiotherapy, chemotherapy, diagnostics, and supportive care services. With three offering proton beam therapy, and the North West coming on stream in the near future to accompany their MRI Linac (which will launch in early 2021).
All centres are fully equipped with IBA Proteus One with on board imaging, pencil beam scanning and 230 MeV protons. In addition, each centre has a Versa HD Elekta LINAC, and a chemotherapy suite, together with full imaging capabilities, with additional Ultra Sound Services at South Wales and Thames Valley.
The North East centre has a one stop breast screening clinic, with plans for other one stop clinics in discussion at the other centres, including Urological clinics.
Through the University of Pennsylvania Health System (Penn Medicine), Rutherford has trained a large number of Consultant Clinical Oncologists in the use of protons.
Our patient referral pathway follows a thorough process to assess the suitability of proton beam therapy for patients. Each case which is passed for proton therapy is then reviewed before treatment by our educational partner Penn Medicine in Philidelphia.
What our patients say
Steps have been put in place to protect patients & staff from the virus and not once have I felt compromised - Rutherford Cancer Centre South Wales
All the staff were fabulous. First class treatment and care was given on each visit - Rutherford Cancer Centre North East
Proton Beam Therapy
The physical properties of protons allows more precise control over where the radiation dose is delivered within the patient, enabling an overall decrease in integral dose, and in many cases dose reduction to organs at risk (OARs) offering a potential reduction in toxicity. These lower OAR doses are achieved while maintaining or improving tumour dose and tumour control and in some cases can help to reduce side-effects sometimes associated with conventional radiotherapy. Proton beam therapy can also be used to treat secondary cancers.
With over 100,000 patients treated globally at proton centres working with our partners IBA, some cases have demonstrated better quality of life during and after treatment, and fewer radiation-induced cancers than with conventional radiotherapy. Comparable scans display cases where both proton and photon radiation were considered for treatment.
Rutherford welcome you to join their network
If you decide to join the Rutherford Cancer Centres you shall become a part of the Rutherford Oncology Network, and shall be introduced to the Rutherford Buddy System, where you will be paired with one of our trained proton beam therapy oncologists to be your support. Our services are planned and delivered in line with requirements of healthcare regulators, professional bodies and national and international best practice. This means that we have policies and processes in place to ensure the quality and safety of service. To become a part of the Rutherford the below processes must completed:
- Practising Privileges (PPs) - Every new clinician joining us must complete their practicing privileges paperwork in order to treat and refer to our centres (PPs are required at each individual centre).
Paperwork is sent via the centre team, and you shall have help, guidance and support should you need anything during the completion.